Global Medicated Skin Care Products Industry (2019 to 2027) - Market Trajectory & Analytics

News provided by

Jun 22, 2020, 15:45 ET

DUBLIN, June 22, 2020 /PRNewswire/ -- The "Medicated Skin Care Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis and the looming economic recession, the Medicated Skin Care Products market worldwide will grow by a projected US$1.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 2.1%. Medicated Skin Care Products, one of the segments analyzed and sized in this study, is forecast to grow at over 2.1% and reach a market size of US$8.1 Billion by the end of the analysis period.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Medicated Skin Care Products market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 1.2% CAGR. Within Europe Germany will add over US$23.2 Million to the region's size over the next 7 to 8 years. In addition, over US$27.9 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Medicated Skin Care Products segment will reach a market size of US$481.8 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Medicated Skin Care Products market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 4.5% over the next couple of years and add approximately US$394.5 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Medicated Skin Care Products market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

Advanced Dermatology Corp.
Bayer AG
Beiersdorf AG
Chattem Inc.
EltaMD Inc.
Episciences Inc.
Galderma S.A.
GlaxoSmithKline Plc
IntraDerm Pharmaceuticals
Johnson & Johnson
Kao Corporation
La Prairie Group AG
Laboratorios Leti SL
L`Oral S.A.
Medimetriks Pharmaceuticals Inc.
Merz Pharma GmbH & Co. KGaA
NEOCUTIS
Obagi Medical Products Inc.
Otsuka Pharmaceutical Co. Ltd.
PCA Skin
Pfizer Inc.
Shiseido Co. Ltd.
SkinCeuticals
SkinMedica Inc.
Skinvisible Pharmaceuticals Inc.
Stiefel Laboratories Inc.
Taisho Pharmaceuticals Co. Ltd.
The Himalaya Drug Company
Unilever NV
Valeant Pharmaceuticals International Inc.
Vivier Pharma
ZO Skin Health Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Medicated Skin Care Products: Medical Solutions for Skin Health Needs
Recent Market Activity
Convergence of Beauty and Healthcare
Growth Drivers in a Nutshell
Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver
Major Skin Diseases: Few Fast Facts
Global Market Outlook
Developed Markets: Traditional Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Competitive Scenario
Leading Players in the Global Medicated Skin Care Products Market
Vendors Emphasize Collaborations
M&A Activity
Select M&A Deals in the Global Medicated Skin Care Products Market in the Recent Past
Global Competitor Market Shares
Medicated Skin Care Products Competitor Market Share Scenario Worldwide (in %): 2019E
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
Health & Wellness Boosts Demand for Dermocosmetics
Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
Major Anti-Aging Ingredients of Cosmeceuticals
Popular Cosmeceutical Contents
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market
Common Skin Care Cosmeceuticals
Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions
Medicated Skin Care Innovations: Spearheading Growth
Innovations for Acne
Innovations for Actinic Keratosis
Innovations for Tuberous Sclerosis Complex and Angiofibromas
Melasma Treatment Innovations
Onychomycosis Treatment Innovations
Innovations for Alopecia/Hair Loss
Stem Cell Technology: The New Frontier?
Intelligent Scanning for Identifying Beneficial Ingredients
Innovations in Anti-Aging Skin Care
Other Noteworthy Medicated Skin Care Innovations
Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
What's Next in Ingredients?
Innovative Ingredients Gain Focus
Aesthetic Dermatology to Witness Sustained Growth
Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market
Surging Popularity of Multi-Functional Products Promote Market Expansion
Sales of Hydroquinone-free Products Gain Momentum
Facial Wipes Offers Huge Untapped Growth Potential
Women: The Dominant Consumer Cluster for Medicated Skin Care Products
Physiological Differences Entail Need for Male Specific Products
Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
Increasing Environmental Pollution Drive Demand for Anti-Pollution Skin Care Products
Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION
Total Companies Profiled: 120

For more information about this report visit https://www.researchandmarkets.com/r/897zma

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets